Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. März 2026 08:30 ET | Quelle: RenovoRx, Inc.

RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment

TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using RenovoCath® as a Stand-Alone Device for...
26. März 2026 08:30 ET | Quelle: Achieve Life Sciences

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

SEATTLE and VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global...
26. März 2026 08:00 ET | Quelle: Daxor Corporation

Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026

OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the...
26. März 2026 07:30 ET | Quelle: Dynacor Group Inc.

Dynacor: Strong Fourth Quarter Caps Record Financial Performance and Expanded Growth Pipeline in 2025

Dynacor Group Inc. (TSX: DNG) today announced its financial and operational results for the year and quarter ended December 31, 2025.
26. März 2026 07:30 ET | Quelle: Medicus Pharma Ltd

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

PHILADELPHIA, March 26, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...
26. März 2026 07:30 ET | Quelle: Wave Life Sciences USA, Inc.

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p<0.05) and total fat (-5%),...
26. März 2026 07:00 ET | Quelle: Verde AgriTech Ltd

Verde AgriTech Announces Q4 & FY 2025 Earnings Results

All figures are in Canadian dollars unless otherwise stated. BELO HORIZONTE, Brazil and SINGAPORE, March 26, 2026 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: NPK | OTCQX: VNPKF) ("Verde” or the...
26. März 2026 07:00 ET | Quelle: Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights

Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026Lead clinical candidate IND filing in...
26. März 2026 07:00 ET | Quelle: Hyperion DeFi, Inc.

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit

Five Diversified, Ramping DeFi Business Lines Delivered Growth Exceeding Q4 Guidance Treasury Exceeds 1.93M HYPE, 1.92M KNTQ, & 1.00M HPL Tokens as of March 23(14) HYPD’s Unique “Triple-Dip”...
26. März 2026 06:36 ET | Quelle: SNS Insider pvt ltd

Intravenous Iron Drugs Market Projected to Hit $8.71 Billion by 2035 – SNS Insider

Austin, United States, March 26, 2026 (GLOBE NEWSWIRE) -- Intravenous Iron Drugs Market Size & Growth Analysis: According to SNS Insider, The global Intravenous Iron Drugs Market was valued at...

Vorherige Seite

Nächste Seite